文献速递神经PET

从阿尔茨海默病连续谱看Centiloid定量与视觉判读淀粉样蛋白PET扫描的一致性

Concordance between Centiloid Quantification and Visual Interpretation of Amyloid PET Scans across the Alzheimer Disease Continuum.
PubMed 文献 · AJNR Am J Neuroradiol · 2025-09-02

该研究前瞻性纳入221名认知受损与认知正常参与者,共247次淀粉样蛋白PET扫描(157次[11C]-PiB,90次[18F]-FBB),评估Centiloid定量与视觉判读判定Aβ阳性的的一致性。全队列最高一致率为93%(CL阈值18,κ=0.84);FBB最佳阈值24一致率97%,PiB最佳阈值18一致率94%。结论认为全局CL定量与视觉判读高度一致,联合两种方法可能更全面评估Aβ沉积范围。

要点

  • 全队列CL阈值18时与视觉判读一致率最高达93%(κ=0.84)。
  • FBB最佳CL阈值24一致率97%,PiB最佳阈值18一致率94%。
  • 不一致常见于视觉判读见局灶性Aβ阳性而全局CL定量未达阈值时。

核心结论

  • 淀粉样蛋白PET的全局Centiloid定量与视觉判读高度一致,联合两种方法可能更全面评估脑内Aβ沉积范围。

研究设计与样本

  • 前瞻性纳入AD研究的221名参与者(平均年龄69±12.3岁),共247次Aβ PET扫描,包括157次[11C]-PiB和90次[18F]-FBB;按全球阿尔茨海默病协会交互网络指南将SUVR转换为Centiloid量表,用百分比一致率和κ统计评估CL阈值与视觉判读判定Aβ阳性的一致性。

关键影像表现/征象

  • 视觉判读见局灶性Aβ阳性但全局CL定量未达阈值时易出现不一致。

诊断标准与关键数值

  • 全队列CL阈值18时与视觉判读一致率最高为93%(κ系数0.84)。
  • FBB最佳CL阈值24时一致率97%,PiB最佳阈值18时一致率94%。
  • Aβ PET阴性病例的一致率98%高于阳性病例的90%。
  • 认知受损参与者的一致率96%略高于认知正常参与者的93%。

临床应用与阅片要点

  • 全局Centiloid定量与视觉判读高度一致,联合两种方法可能更全面评估Aβ沉积范围(作者结论)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Accurate identification of cerebral β-amyloid (Aβ) accumulation is crucial for diagnosing Alzheimer disease (AD) and determining eligibility for anti-Aβ therapies. The Centiloid (CL) scale has emerged as a standardized method to harmonize Aβ PET quantification across different tracers and sites. We aimed to evaluate the concordance between CL quantification and visual interpretation in a cohort of cognitively impaired (CI) and unimpaired (CU) participants who underwent Aβ PET.

MATERIALS AND METHODS: Two hundred twenty-one participants (mean age 69 ± 12.3 years) were prospectively enrolled in AD studies and underwent 247 Aβ PET scans, including 157 with [11C]-Pittsburgh compound B (PiB) and 90 with [18F]-florbetaben (FBB). Standardized uptake value ratios (SUVRs) were converted to the CL scale following Global Alzheimer's Association Interactive Network guidelines. Percent agreement and κ statistics were used to evaluate the concordance between CL thresholds and visual interpretation in determining Aβ positivity.

RESULTS: The highest concordance rate for the whole cohort was 93% by using a CL cutoff of 18 (κ coefficient 0.84). Using FBB, the concordance rate was highest by using a CL cutoff of 24 (97%), whereas the concordance rate for PiB peaked at 94% at a CL cutoff of 18. Concordance was higher in negative rather than positive Aβ PET cases, 98% versus 90%. Concordance was slightly higher in CI participants compared with CU (96% versus 93%). Disagreement commonly occurred when focal areas of Aβ positivity were identified on visual interpretation but did not meet the threshold globally by CL quantification.

CONCLUSIONS: Global CL quantification of Aβ PET scans is highly concordant with visual interpretation. Combining both methods may provide a more complete assessment of the extent of Aβ deposition in the brain.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Khalafi M, Hojjati SH, Wang XH, et al. Concordance between Centiloid Quantification and Visual Interpretation of Amyloid PET Scans across the Alzheimer Disease Continuum. AJNR Am J Neuroradiol. 2025. PMID: 40101933. doi:10.3174/ajnr.A8743

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。